MANAGEMENT AND OUTCOME OF BASELINE GREYZONE ( GZ) PATIENTS AMONG THE FRENCH HEPATHER COHORT: IS IT DIFFERENT FROM HBEAG NEGATIVE CHRONIC HEPATITIS B INFECTION ( CHBVE-) OR HBEAG NEGATIVE CHRONIC HEPATITIS ( CHBVHE-)?

被引：0
|
作者：
Parlati, Lucia [1 ]
Lusivika, Clovis [2 ]
Nicol, Jerome [2 ]
Carrat, Fabrice [2 ]
Leroy, Vincent [3 ]
Bourliere, Marc [4 ]
机构：
[1] Cochin Hosp, Hepatol Dept, Kochi, Japan
[2] INSERM Paris, IPLESP, UMR S 1136, Paris, France
[3] Mondor Hosp, Hepatol Dept, Creteil, France
[4] Hop St Joseph, Paris, France
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
301
引用
收藏
页码：S215 / S216
页数：2
相关论文
共 50 条
  • [31] Biochemical response to lamivudine treatment in HBeAg negative chronic hepatitis B patients in Iran
    Alizadeh, Amir Houshang Mohammad
    Ranjbar, Mitra
    Karimi, Babak
    Hatami, Saeed
    WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (26) : 4203 - 4205
  • [32] HBV DNA change between HBeAg positive and negative patients with chronic hepatitis B
    Liu, J.
    Zhang, J.
    Lin, C. -S.
    Xu, Z.
    Gao, Z. -L.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2011, 15 : S29 - S29
  • [33] CLINICAL PROGNOSIS OF HBEAG- NEGATIVE PATIENTS WITH CHRONIC HEPATITIS B WITH LOW HBSAG
    Wang, Jian
    Zhu, Li
    Zhang, Zhiyi
    Yin, Shengxia
    Zhang, Shaoqiu
    Fan, Tao
    Xiong, Ye
    Jiang, Chao
    Liu, Xingxiang
    Li, Jie
    Zhu, Chuanwu
    Wu, Chao
    Huang, Rui
    HEPATOLOGY, 2024, 80 : S297 - S298
  • [34] Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine
    Di Marco, V
    Marzano, A
    Lampertico, P
    Andreone, P
    Santantonio, T
    Ahnasio, PL
    Rizzetto, M
    Craxì, A
    HEPATOLOGY, 2004, 40 (04) : 883 - 891
  • [35] HEPATITIS B CORE RELATED ANTIGEN MAY BE A MARKER FOR IMMUNE CONTROL IN HBeAg NEGATIVE CHRONIC HEPATITIS B INFECTION
    Van Campenhout, M. J.
    Brouwer, W. P.
    Janssen, H. L.
    Xie, Q.
    Zhang, Q.
    Tabak, F.
    Streinu-Cercel, A.
    Wang, J.
    van Oord, G.
    de Knegt, R. J.
    Boonstra, A.
    Hansen, B. E.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S547 - S547
  • [36] Does HBV DNA level predict outcome in HBeAg-negative chronic hepatitis B?
    Feld, JJ
    Tellier, R
    Ayers, M
    El-Ashry, D
    Arenovich, T
    Mazzuli, A
    Heathcote, EJ
    GASTROENTEROLOGY, 2005, 128 (04) : A739 - A739
  • [37] Comparison of Serum Hepatitis B Virus DNA and HBsAg Levels Between HBeAg-Negative and HBeAg-Positive Chronic Hepatitis B Patients
    Keshvari, Maryam
    Alavian, Seyed Moayed
    Sharafi, Heidar
    JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2015, 8 (03)
  • [38] Characterization of Serum HBV RNA in Patients with Untreated HBeAg-Positive and -Negative Chronic Hepatitis B Infection
    Li, Yutang
    He, Lingyuan
    Li, Yao
    Su, Mingze
    Su, Jian
    Hou, Jinlin
    Deng, Juan
    Wang, Shuai
    Wang, Qiangyi
    Xu, Xizhan
    Zhuang, Hui
    Li, Tong
    HEPATITIS MONTHLY, 2018, 18 (02)
  • [39] Impact of HBsAg level on cellular immune responses in HBeAg negative patients with chronic hepatitis B virus infection
    Aliabadi, Elmira
    Mix, Carola
    Manns, Michael P.
    Kraft, Anke
    Cornberg, Markus
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E445 - E445
  • [40] The Direct Medical Cost of Regular Monitoring of Patients with HBeAg-Negative Chronic Hepatitis B Virus Infection
    Emecen, Ahmet Naci
    Caskurlu, Hulya
    Ergen, Pinar
    Cag, Yasemin
    Arslan, Ferhat
    Vahaboglu, Haluk
    VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2022, 28 (02): : 61 - 66
12345